[1]
Najmeh Moradi, Leila Zarei, Shahram Tofighi, Marzieh Zanganeh, and Ali Akbari Sari, “Economic Evaluation of Infliximab for Treatment of Refractory Ulcerative Colitis in Iran: Cost-Effectiveness Analysis: Economic Evaluation of Infliximab in UC Patients”, Iran J Pharm Sci, vol. 12, no. 4, pp. 33–42, Oct. 2016.